Lv21
130 积分 2025-03-06 加入
Olverembatinib After Failure of Tyrosine Kinase Inhibitors, Including Ponatinib or Asciminib
1个月前
已完结
Olverembatinib: First Approval
1个月前
已完结
Amphotericin B Formulations: A Comparative Review of Efficacy and Toxicity
1个月前
已完结
A Randomized, Double-Blind Comparative Trial Evaluating the Safety of Liposomal Amphotericin B versus Amphotericin B Lipid Complex in the Empirical Treatment of Febrile Neutropenia
2个月前
已完结
皖公网安备34019202002308
